TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 44 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $492,000 | -88.1% | 321,600 | -57.1% | 0.02% | -91.6% |
| Q2 2016 | $4,128,000 | -9.4% | 749,205 | -7.8% | 0.22% | -5.7% |
| Q1 2016 | $4,556,000 | -32.7% | 812,200 | +24.1% | 0.23% | -18.3% |
| Q3 2015 | $6,772,000 | +297.7% | 654,283 | +411.0% | 0.28% | +350.0% |
| Q2 2015 | $1,703,000 | – | 128,041 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 132,500 | $1,155,000 | 1.36% |
| Novo Holdings A/S | 470,946 | $4,107,000 | 0.40% |
| Opus Point Partners Management, LLC | 62,007 | $541,000 | 0.36% |
| Perceptive Advisors | 485,338 | $4,232,000 | 0.31% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $305,000 | 0.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 87,983 | $767,000 | 0.04% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $52,000 | 0.02% |
| Alyeska Investment Group, L.P. | 251,797 | $2,196,000 | 0.02% |
| A.R.T. Advisors, LLC | 27,490 | $239,000 | 0.01% |
| ALPS ADVISORS INC | 29,753 | $259,000 | 0.00% |